21 Aug, 16:00 EDT

Shares of Micron Technology dropped roughly 3% in U.S. premarket trade on Monday, after a significant decline in Asian memory stock prices and softer Nasdaq futures.
NASDAQ: MU · Memory cycle stress test
21 Aug, 16:00 EDT
Reported 24 Aug, 05:26 EDT
17–21 Aug closes
+56.7% vs last close
Closes: $1,011.75 · $940.76 · $937.11 · $974.33 · $966.78
Peer capital-return disappointment hit a crowded memory trade. New Chinese funding adds a longer-dated supply question.
Micron fiscal Q3 2026. Bars use revenue as the scale anchor, except margin.
| Firm | View | Target |
|---|---|---|
| UBS | Buy | $1,625 |
| BofA | Buy | $1,550 |
| New Street | Buy | $1,250 |
| Consensus | Strong Buy | $1,515 |
47 analysts: 34 Strong Buy, 9 Buy, 4 Hold, 0 Sell.
Micron's earnings case remains strong. The new risk is expectation density: record margins, sustained AI spending and disciplined industry supply are all embedded in the bullish consensus.
Market data: Nasdaq/StockAnalysis and MarketWatch, captured 24 Aug 2026 at 05:26 EDT. Financials: Micron fiscal Q3 2026. Analyst targets: S&P Global/Investing.com snapshot. Premarket data is indicative and may move sharply before the open.
| Company | Ticker | Move | Signal |
|---|---|---|---|
| Bajaj Hindusthan | NSE:BAJAJHIND | ~+11% | Momentum held |
| Shree Renuka | NSE:RENUKA | ~+7% | Import-linked buying |
| Triveni Engineering | NSE:TRIVENI | ~+2% | Integrated model lagged |
| Balrampur Chini | NSE:BALRAMCHIN | −1.6%* | Early gain reversed |
MSTR outran bitcoin last week. That added upside beta, but the treasury’s mark-to-market gain remains small relative to the stock move.
Market data: Friday, August 21, 2026, 4:00 PM EDT. Holdings: August 16, 2026. U.S. equities closed; crypto trades continuously. Prepared Sunday, August 23, 2026, 8:02 PM EDT.
| Week through Aug. 16 | Amount | Read-through |
|---|---|---|
| MSTR shares sold | 3.46M | Common dilution funded liquidity |
| Net proceeds | $333.7M | No bitcoin bought or sold |
| USD reserve addition | $149.1M | Reserve reached $4.8B |
| STRC repurchases | $132.2M | Reduced preferred overhang |
| Preferred dividends | $52.4M | Recurring claim ahead of common |
Sources: WSJ and FT market reports; StockAnalysis closing data; Strategy’s August 17 filing as summarized by The Block; Investing.com analyst consensus. Values are rounded. Treasury gain is a preliminary gross mark before debt, preferred claims, taxes, fees or dilution.
The stock rallied after FY26 results shifted attention from falling profit to asset sales, cash conversion and cost benefits.
Market open
Price: August 24, 2026, 10:26 a.m. NZST
NZX data delayed 20 minutes
The rally capitalises 71% of the FY28 benefit target. Delivery still matters.
| Underlying | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue | NZ$822.7m | NZ$825.2m | -0.3% |
| EBITDA | NZ$181.6m | NZ$233.7m | -22.3% |
| EBITDA margin | 22.1% | 28.3% | -6.2pp |
| Net profit | NZ$38.0m | NZ$71.5m | -46.9% |
| Operating cash inflow | NZ$121.7m | NZ$45.2m | +169.4% |
The asset programme equals 38%–42% of current market value. The Grand hotel agreement remains non-binding.
| Mean recommendation | BUY |
| Analysts | 4 |
| Average target | NZ$1.012 · +55.7% |
| Low target | NZ$0.800 · +23.1% |
| High target | NZ$1.500 · +130.8% |
Targets may lag the newest earnings information.
| September 2026 | NZ$74.5m office-sale settlement |
| Late 2026 | Online-casino licence decisions expected |
| FY27 | NZ$30m annualised operating benefits |
| FY27 | Leverage below 2.0× |
| FY28 | NZ$70m total benefits target |
Soft discretionary spending, Adelaide remediation costs and the May 2027 bond maturity still matter. Asset-sale delays or weak savings would reopen the funding question. The regulated online opportunity is not secured; SkyCity must win a licence before it can participate.
| Measure | Value | From $947.74 |
|---|---|---|
| Consensus | Buy | 39 analysts |
| Average target | $1,077 | +13.7% |
| Low target | $740 | -21.9% |
| High target | $1,315 | +38.8% |
Medicare adds commission potential, store visits and another retention touchpoint. Strong sales and renewal rates fund the experiment.
Rules bar membership bundling. Weak conversion or delayed approval would leave investors paying roughly 46 times forward earnings for the core story alone.
The market needs numbers before treating Medicare as a material earnings driver.
Strategic win Google can earn warrants as purchases scale. The agreement broadens Marvell’s custom-AI role.
Not backlog The $120B figure is a cumulative ceiling tied to 240 revenue milestones.
Expectation risk Friday’s 5.6% drop showed investors are already demanding proof.
| Measure | Value | Read-through |
|---|---|---|
| Maximum shares | 58.97M | ≈6.7% potential dilution |
| Exercise price | $206.58 | 12.9% below Friday |
| Time-based shares | 1.36M | Small fixed portion |
| Revenue tranches | 240 × $500M | $120B ceiling |
| Horizon | FY2033 | Long execution runway |
RBC expects a slight beat and a 2%–4% lift to next-quarter guidance, led by optical demand.
| Firm | View | Target | Upside |
|---|---|---|---|
| BMO | Outperform | $250 | 5.5% |
| Citigroup | Buy | $275 | 16.0% |
| Oppenheimer | Outperform | $300 | 26.6% |
| UBS | Buy | $310 | 30.8% |
| RBC | Outperform | $360 | 51.9% |
The Google deal reduces strategic doubt. It does not remove execution risk. The best near-term signal is whether Marvell converts AI bookings into revenue while keeping gross margin near 59%.
Risk: delayed purchases, tight wafer supply, weaker guidance or warrant dilution can unwind the premium quickly.
AI funding versus dilution · weekend investor dashboard
Market data: Aug. 21, 2026, 16:00 EDT
Profit reset: net income fell 75% as investment accelerated.
Fresh supply: the new shares equal about 3.8% of the quarter's weighted basic count.
Growth offset: AI Cloud revenue rose 45% and adjusted EBITA rose 133%.
Sources: Alibaba Group June-quarter results and placement pricing; Reuters; Stock Analysis. Prices are historical and reflect the Aug. 21, 2026 NYSE close at 16:00 EDT. Placement USD values use the reported HKD/USD conversion. Markets were closed when this dashboard was prepared.
| Eligible shares | 319.0M |
| Aug. 20 volume | 119.0M |
| Aug. 21 volume | 78.1M |
| Two-day move | -1.92% |
| Segment | Revenue | YoY | Share |
|---|---|---|---|
| Connectivity | $4.29B | +66% | 54.9% |
| AI | $2.56B | +247% | 32.8% |
| Space | $0.96B | +29% | 12.3% |
| Segment | Operating result | Capex |
|---|---|---|
| Connectivity | +$1.66B | $1.37B |
| Space | -$0.54B | $1.17B |
| AI | -$1.26B | $15.83B |
| Group | -$0.14B | $18.37B |
| Morgan Stanley / Buy | $300 |
| Clear Street / Buy | $217 |
| DZ Bank / Sell | n/a |
Sources: SpaceX SEC Form 10-Q and Q2 earnings release; SEC IPO filing; MarketWatch; S&P Global Market Intelligence and TipRanks via StockAnalysis. Calculations are preliminary and may differ due to rounding.
| Metric | Q3 FY26 | YoY |
|---|---|---|
| Revenue | $109.4B | +16.4% |
| Services | $30.739B | +12.1% |
| Net income | $29.789B | +27.1% |
| Diluted EPS | $2.02 | +28.7% |
| Company | Forward P/E | 52-week move | Read-through |
|---|---|---|---|
| Apple | 33.78× | +36.87% | Highest multiple in group |
| Amazon | 27.91× | +15.56% | Commerce + cloud |
| Alphabet | 25.87× | +73.00% | Ad and AI scale |
| Microsoft | 24.49× | −4.45% | Enterprise AI |
| Meta | 17.17× | −26.46% | Lowest multiple |
| Delivery window | Contract | Expected |
|---|---|---|
| H2 2026 | 3 | 0 |
| 2027 | 44 | 20 |
| After 2027 | 120 | 147 |
The deal may improve manufacturing. The stock still needs rapid order conversion, fewer losses and disciplined integration to defend its premium.
Nine analysts: seven Strong Buy, two Buy.
High short interest can amplify rallies and declines.
Sources: Ondas Q2 2026 and Aran Defense releases; StockAnalysis price history, statistics and analyst forecasts. Company guidance and targets are forecasts, not guarantees.
Consensus: Strong Buy. Twenty-seven of 28 recommendations are Buy or Strong Buy.
The market punished loss of marketing control, then bought the schedule. Thursday's August 27 extended preview is the next measurable checkpoint. Engagement and a firm November 19 release date matter more than the leaked clips themselves.
The stock recovered faster than analysts raised targets. Consensus now implies only 3.92% upside, while the $174–$350 range signals deep disagreement.
Forecasts from 25 analysts. The spread is $176.
Consensus label: Buy. The mix is less bullish than the headline suggests.
Sources: IBM Q2 2026 results and August 19 quantum update; StockAnalysis price history and analyst forecasts; MarketWatch peer comparison. Forecasts are not guarantees.
| Stock | Market cap | TTM sales | P/S |
|---|---|---|---|
| QUBT | $2.02B | $9.82M | 206× |
| IONQ | $17.89B | $246.47M | 73× |
| RGTI | $5.98B | $13.35M | 448× |
| QBTS | $7.49B | $12.43M | 603× |
Sector rotation, not fresh company news.
QUBT rallied with IONQ, RGTI and QBTS after three declining sessions. The volume jump supports a risk-on move. The latest company earnings release remains the Aug. 10 Q2 report.
A close above $9.18 would strengthen the rebound. A break below $8.14 would return focus to execution, spending and order conversion.
*Preliminary total-return estimate adds back the A$2.70 final dividend that went ex on Wednesday.
| Rating | Count | Share |
|---|---|---|
| Strong sell | 11 | 79% |
| Sell | 3 | 21% |
| Hold / Buy | 0 | 0% |
| Average target | A$125.21 | −20.75% |
| Highest target | A$144.99 | −8.23% |
The bearish consensus is unusual in its unanimity. Even the highest tracked target remains below Friday's close.
Investor read: Holding A$156.44 would keep Friday's bounce alive. A failure there would put the residual de-rating—not the dividend adjustment—back at the centre of the trade.
Recent calls: JPMorgan Buy, A$67; RBC Hold, A$60; Macquarie Hold, A$55.
Target range: A$42.76–A$91.09. The spread shows how strongly commodity assumptions drive valuation.
A copper reversal would hit the new earnings narrative first. Higher FY2027 capital spending, the Jansen potash cost overrun and Western Australian iron-ore industrial action could also challenge the rerating. The stock is already above the average analyst target.
| Target | Value | Vs. $344.82 |
|---|---|---|
| Consensus average | $428.04 | +24.13% |
| Low | $340 | −1.40% |
| High | $515 | +49.35% |
| Metric | 2026 | Comparison |
|---|---|---|
| Cash & securities | $237.9m | −$80.2m in H1 |
| Q2 operating expense | $42.9m | +55.0% YoY |
| Q2 net loss | $40.7m | +57.2% YoY |
| Runway at H1 loss pace | ~19 months | Preliminary |
| Firm | Action | Rating | Target | Versus $6.29 |
|---|---|---|---|---|
| Cantor Fitzgerald | Upgrade | Buy | $28 | +345% |
| Piper Sandler | Maintain | Hold | $2 | −68% |
| B. Riley | Maintain | Hold | $5 | −21% |
| Consensus | — | Hold | $10.50 avg. | +67% |
| Median | — | — | $6 | −5% |
Today’s highest-ranked model selections.
The catalysts most likely to move markets.
A surprise around the 0.10 forecast could shift the morning growth narrative and influence Treasury yields and the dollar before the opening bell.
The day’s largest scheduled equity report can move PDD and the broader China-internet / e-commerce complex through revenue growth, margins and Temu commentary.
Deliveries, margin progression and spending on AI-enabled mobility can affect U.S.-traded Chinese EV names and related technology suppliers.